Article
Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts…
medRxiv · 2024 · Nguyen, H. N.; Jeong, Y.; Kim, Y.; Kim, Y. H.; Athar, H.; Castaldi, P. J.; Hersh, C. P.; Padera, R. F.; Sholl, L. M.; Vivero, M.; Sharma, N. S.; Yun, J.; Merriam, L. T.; Yuan, K.; Kim, E. Y.; Brenner, M. B.
Key facts
| Title | Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis |
|---|---|
| First author | Nguyen, H. N.; Jeong, Y.; Kim, Y.; Kim, Y. H.; Athar, H.; Castaldi, P. J.; Hersh, C. P.; Padera, R. F.; Sholl, L. M.; Vivero, M.; Sharma, N. S.; Yun, J.; Merriam, L. T.; Yuan, K.; Kim, E. Y.; Brenner, M. B. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.05.21.595153 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, JJH, KIP, KIT, MVU, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1